SCHEMBL30742673

SCHEMBL30742673

CC(C)(C)OC(=O)N1CC[C@H](Oc2ccnc(COc3ccc(Cl)cc3F)c2)C[C@@H]1CO

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ USP30 Q70CQ3 1/20 0.37
▸ GPR119 Q8TDV5 4/20 0.36
▸ HTR2C P28335 2/20 0.35
▸ HTR2B P41595 2/20 0.35
▸ SLC6A4 P31645 1/20 0.35
▸ CYP3A4 P08684 2/20 0.35
▸ CYP3A5 P20815 2/20 0.35
▸ LNPEP Q9UIQ6 3/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ SCN9A Q15858 1/20 0.34
▸ MRGPRX4 Q96LA9 1/20 0.34
▸ APP P05067 1/20 0.34
▸ HTR1A P08908 1/20 0.34
▸ ADRA2A P08913 1/20 0.34
▸ DRD2 P14416 1/20 0.34
▸ ADRA2B P18089 1/20 0.34
▸ ADRA2C P18825 1/20 0.34
▸ SLC6A2 P23975 1/20 0.34
▸ HRH2 P25021 1/20 0.34
▸ HTR1D P28221 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27478001 1.00 USP30 (0.37) USP30GPR119HTR2CHTR2BSLC6A4
SCHEMBL27477980 0.91 USP30 (0.38) USP30GPR119HTR2CHTR2BSLC6A4
SCHEMBL29826215 0.78 CYP2C9 (0.44) GPR119LNPEPNEK2
SCHEMBL29826391 0.78 CACNB4 (0.44) GPR119LNPEPNEK2
SCHEMBL29826118 0.77 CACNB4 (0.44) GPR119LNPEPNEK2
SCHEMBL29826647 0.75 GPR119 (0.47) GPR119LNPEPNEK2
SCHEMBL29826839 0.75 PDE4A (0.43) GPR119LNPEPNEK2
SCHEMBL30745378 0.75 SCN9A (0.39) GPR119LNPEPALDH1A1SCN9A
SCHEMBL29826311 0.74 LNPEP (0.42) GPR119LNPEP
SCHEMBL30742702 0.74 SLC6A4 (0.41) HTR2CHTR2BSLC6A4MRGPRX4SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4562006-A1 N-HETEROCYLIC GPCR RECEPTOR AGONISTS, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME, AND METHODS FOR THEIR USE Carmot Therapeutics, Inc. (US) 2025-06-04 — — EP disclosed
WO-2024026338-A1 N-HETEROCYLIC GPCR RECEPTOR AGONISTS, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME, AND METHODS FOR THEIR USE CARMOT THERAPEUTICS, INC. (US) 2024-02-01 — — WO disclosed
Send feedback